JAN 04, 2020 11:41 AM PST

Why Do Skincare Products Sometimes Cause Rashes?

WRITTEN BY: Kara Marker

Chemicals commonly found in skincare products are intended to avoid interactions with the part of the immune system responsible for triggering allergic inflammatory responses. However, allergic reactions to skincare products are common, so what mechanisms can be held responsible for this unintentional health issue?

Everyday Health estimates that up to 24 percent of Americans will experience allergic reactions involving their skin at some point in life, often due to chemical compounds in skincare products like lotion and makeup. This type of allergy is called allergic contact dermatitis, one type of allergic response characterized by chemical contact with human skin that is sensitized to that particular chemical. This condition causes an inflammatory response, and common stimuli include poison ivy, nickel, rubber, and cosmetics.

In any allergic or autoimmune response, T cells of the human immune system perceive certain chemicals as foreign objects, such as a particular chemical in a skincare product. Because of this recognition and labeling as “foreign,” the T cells set things in motion for an inflammatory immune response to target the foreign chemicals.

But before T cells are able to recognize chemicals and trigger an immune response, certain cellular interactions involving these chemicals must occur. Small chemical compounds in skincare products are designed to “lack the chemical groups needed for this reaction to occur,” and in theory they should subsequently be “invisible” to T cells. However, allergic reactions to skincare products do occur, so what’s happening in the body to trigger such reactions?

New research shows that CD1a molecules from immune cells in the outer layer of the skin, called Langerhans cells, are involved in reacting with skincare product chemicals to make them recognizable by T cells. Normally CD1a molecules do not interact with T cells because of a lipid barrier that results from CD1a lipid binding.

Researchers from the current study observed chemicals commonly associated with skincare products and allergic contact dermatitis binding CD1a molecules, ultimately stimulating a reaction with T cells.

Uncovering physiological mechanisms like chemical interactions with CD1a molecules can help scientists develop new ways to treat allergic contact dermatitis or prevent the allergic reactions from occurring in the first place. For example, CD1a-directed interactions between external chemicals from skincare products and T cells could be prevented by supplementing the skin with additional lipids to support the lipid barrier between CD1a and T cells. Until researchers identify more causes of allergic contact dermatitis, the only other solution to prevent allergic reactions would be to avoid contact with chemicals that are known to cause an allergic reaction for a particular individual.

Sources: Columbia University Irving Medical Center, Science Immunology, “Allergic Contact Dermatitis

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 05, 2020
Immunology
Intercepting Cancer Cells Before They Can Dodge the Immune System
AUG 05, 2020
Intercepting Cancer Cells Before They Can Dodge the Immune System
The battle that naturally occurs between the body’s immune system and cancerous cells is one that scientists have ...
SEP 08, 2020
Immunology
Regular Opioid Users Are More Sensitive to Pain, Immune System to Blame
SEP 08, 2020
Regular Opioid Users Are More Sensitive to Pain, Immune System to Blame
Opioids are painkillers such as oxycodone (OxyContin and Percocet) and hydrocodone (Vicodin) that are synthesized to mim ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
NOV 02, 2020
Immunology
New Cancer Drug Reboots Stalled Immunotherapies
NOV 02, 2020
New Cancer Drug Reboots Stalled Immunotherapies
In contrast to traditional chemotherapies, immunotherapies reprogram the patient’s own immune system to fight tumo ...
NOV 25, 2020
Immunology
Another COVID-19 vaccine shows promising results!
NOV 25, 2020
Another COVID-19 vaccine shows promising results!
A week ago, another biotechnology company "Moderna" announced the preliminary results from its COVID-19 vaccin ...
Loading Comments...